Home Business Opportunities Licensing New Products/Technologies New Leads
Antirelapse Antimalarial (Synthetic)
 

-

1 A primaquine derivative effective in treatment of relapsing malaria and transmission blocking.
2 Safer than primaquine in terms of Met-hemoglobin toxicity and high therapeutic index.
 

IPR covered:
 
Country Details
1. US

Application No. 09/316313
2. India

Application No. 655/DEL/99 filed on 24/12/1999

.

The Organisation | Programme & Activities | Expertise Available | Achievements | Business Opportunities
| Career Opportunities
.